Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2012
08/09/2012US20120202886 Method of enhancing hair growth
08/09/2012US20120202885 Methods, assays and compositions for treating retinol-related diseases
08/09/2012US20120202884 Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets
08/09/2012US20120202883 Effects of idh1 and idh2 mutations on the cellular metabolome
08/09/2012US20120202882 Permeation enhancers for topical formulations
08/09/2012US20120202881 Novel NIDDM Regimen
08/09/2012US20120202880 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202879 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202878 Method for treating psoriasis
08/09/2012US20120202877 Anti-influenza agents
08/09/2012US20120202876 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/09/2012US20120202875 Method Of Treatment
08/09/2012US20120202874 Antisense oligonucleotide modulation of stat3 expression
08/09/2012US20120202873 RNAi Probes Targeting Cancer-Related Proteins
08/09/2012US20120202872 Methods and compositions for the diagnosis and prognosis of cervical intraepithelial neoplasia and cervical cancer
08/09/2012US20120202871 Cationic lipids and methods for the delivery of therapeutic agents
08/09/2012US20120202870 Treatment of inflammatory diseases using mir-124
08/09/2012US20120202869 Antidepressant Oral Pharmaceutical Compositions
08/09/2012US20120202868 Method for treatment of bronchial asthma
08/09/2012US20120202866 Buccal, polar and non-polar spray containing ondansetron
08/09/2012US20120202865 Substituted-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
08/09/2012US20120202864 Compositions and Methods for Treatment of Glaucoma
08/09/2012US20120202863 Compositions and methods for treatment of glaucoma
08/09/2012US20120202862 Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
08/09/2012US20120202861 Novel estrogen receptor ligands
08/09/2012US20120202860 Analgesic Compounds, Compositions and Uses Thereof
08/09/2012US20120202859 Macrocyclic Inhibitors of Hepatitis C Virus
08/09/2012US20120202858 Solid Pharmaceutical Dosage Form
08/09/2012US20120202857 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
08/09/2012US20120202856 Substituted benzimdazole derivatives useful as trpm8 receptor modulators
08/09/2012US20120202855 Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
08/09/2012US20120202854 4-substituted phenoxyphenylacetic acid derivatives
08/09/2012US20120202853 Substituted pyrazoles as estrogen receptor ligands
08/09/2012US20120202852 Heterocycle amide t-type calcium channel antagonists
08/09/2012US20120202851 Pim kinase inhibitors and methods of their use
08/09/2012US20120202850 Method for treating thrombosis and inhibiting platelet aggregation with 21-(s)-argatroban
08/09/2012US20120202849 Pharmaceutical compositions for the treatment/prophylaxis of non-alcoholic fatty liver disease
08/09/2012US20120202848 Therapy of autoimmune colitis using a tip60 inhibitor
08/09/2012US20120202847 Novel Tetrahydroisoquinoline Compounds
08/09/2012US20120202846 Molecular target of neurotoxicity
08/09/2012US20120202845 Diuretics
08/09/2012US20120202844 Crystal Forms of Kinase Inhibitors
08/09/2012US20120202843 H3K27me3 and Cancer
08/09/2012US20120202842 2-heteroarylcarboxylic acid amides
08/09/2012US20120202841 Topical Compositions Comprising Ascomycins
08/09/2012US20120202840 Use of Flubendazole and Vinca Alkaloids for Treatment of Hematological Diseases
08/09/2012US20120202839 Methods and compositions for deterring abuse of orally administered pharmaceutical products
08/09/2012US20120202838 Drug formulations
08/09/2012US20120202837 Spirocyclic piperidine derivatives useful as renin inhibitors
08/09/2012US20120202836 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
08/09/2012US20120202835 Combination
08/09/2012US20120202834 Glucagon receptor modulators
08/09/2012US20120202833 Tricyclic pyrazolopyrimidine derivatives
08/09/2012US20120202832 Kinase inhibitors, prodrug forms thereof and their use in therapy
08/09/2012US20120202831 Pharmaceutical Formulation
08/09/2012US20120202830 Substituted xanthine derivatives
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202828 Fused aminodihydropyrimidone derivatives
08/09/2012US20120202827 Sulfoxide derivatives for the treatment of tumors
08/09/2012US20120202826 Tetrahydropyrrolopyrimidinediones And Their Use In Therapy
08/09/2012US20120202825 Soluble Salts of Thieno [2,3-d] Pyrimidine Derivatives
08/09/2012US20120202824 Pyrazines as delta opioid receptor modulators
08/09/2012US20120202823 Multi-API Loading Prodrugs
08/09/2012US20120202822 Combination
08/09/2012US20120202821 Conformationally constrained, fully synthetic macrocyclic compounds
08/09/2012US20120202820 Pharmaceutical composition having the active substances metformin and sitagliptin or vildagliptin
08/09/2012US20120202819 Combination therapy using a beta 3 adrenergic receptor agonists and an antimuscarinic agent
08/09/2012US20120202818 Ureidophenyl substituted triazine derivatives and their therapeutical applications
08/09/2012US20120202817 Compounds having 4-pyridylalkylthio group as a substituent
08/09/2012US20120202816 Novel compounds
08/09/2012US20120202814 Compounds with ddx3 inhibitory activity and uses thereof
08/09/2012US20120202813 Triazole compounds that modulate hsp90 activity
08/09/2012US20120202812 Heteroaryls and uses thereof
08/09/2012US20120202811 Novel compounds
08/09/2012US20120202810 Substituted 4-aminocyclohexane derivatives
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202808 Novel thiophenediamine derivative having urea structure
08/09/2012US20120202807 Azabicycloalkane derivatives, preparation thereof and use thereof in therapy
08/09/2012US20120202806 Novel Pyrimidine- And Triazine-Hepcidine Antagonists
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202804 Fused aminodihydro-oxazine derivatives
08/09/2012US20120202803 N-[3-(5-amino-3,3a,7,7a-tetrahydro-1h-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as bace1 and/or bace2 inhibitors
08/09/2012US20120202802 Spirocyclic compounds as modulators of chemokine receptor activity
08/09/2012US20120202801 Methods for treating breast cancer
08/09/2012US20120202800 Dual small molecule inhibitors of cancer and angiogenesis
08/09/2012US20120202799 Condensed Azepine Derivatives As Bromodomain Inhibitors
08/09/2012US20120202798 COMPOSITIONS CONTROLLING pH RANGE OF RELEASE AND/OR RELEASE RATE
08/09/2012US20120202797 SUBSTITUTED [(5H-PYRROLO[2,1-c][1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
08/09/2012US20120202796 Method for combating adverse effects arising from antipsychotic treatment
08/09/2012US20120202795 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
08/09/2012US20120202794 Compounds
08/09/2012US20120202793 Rho kinase inhibitors
08/09/2012US20120202792 Antimicrobial Compounds and Methods of Making and Using the Same
08/09/2012US20120202791 Tricyclic and Tetracyclic Systems with Activity on the Central Nervous and Vascular Systems
08/09/2012US20120202790 [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists
08/09/2012US20120202789 Compositions and methods for the treatment of cancer
08/09/2012US20120202788 Azabenzothiazole compounds, compositions and methods of use
08/09/2012US20120202787 Novel Heteroaryl Imidazoles And Heteroaryl Triazoles As Gamma-Secretase Modulators
08/09/2012US20120202786 Therapeutic isoxazole compounds
08/09/2012US20120202785 Heterocyclic compounds and methods of use
1 ... 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 ... 7860